Stock Track | SHINEWAY PHARM Soars 5.09% Intraday on Strong Earnings, Procurement Wins and Dividend Announcement

Stock Track

Mar 27

SHINEWAY PHARM's stock price soared 5.09% during intraday trading on Friday, following the release of its annual financial results and other positive corporate announcements.

The company reported an annual profit increase of 13.1% to 950 million yuan for the fiscal year ended December 31, 2025, despite a decrease in overall revenue. Furthermore, the group successfully secured bids for eight key products in the National Chinese Patent Medicine Purchasing Alliance's centralized procurement program, covering major therapeutic areas. This success is expected to enhance future market demand and sales potential for its products.

Additionally, the company declared a first interim dividend of RMB 0.43 per share for the 2026 financial year, providing a return to shareholders. These combined positive developments likely contributed to increased investor confidence and the significant upward movement in the stock price.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1110490559"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1110490559\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1110490559?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-27 13:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1110490559","market":"us","top_or_hot":-1,"title":"Stock Track | SHINEWAY PHARM Soars 5.09% Intraday on Strong Earnings, Procurement Wins and Dividend Announcement","media":"Stock Track","content":"<p>SHINEWAY PHARM's stock price soared 5.09% during intraday trading on Friday, following the release of its annual financial results and other positive corporate announcements.</p><p>The company reported an annual profit increase of 13.1% to 950 million yuan for the fiscal year ended December 31, 2025, despite a decrease in overall revenue. Furthermore, the group successfully secured bids for eight key products in the National Chinese Patent Medicine Purchasing Alliance's centralized procurement program, covering major therapeutic areas. This success is expected to enhance future market demand and sales potential for its products.</p><p>Additionally, the company declared a first interim dividend of RMB 0.43 per share for the 2026 financial year, providing a return to shareholders. These combined positive developments likely contributed to increased investor confidence and the significant upward movement in the stock price.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | SHINEWAY PHARM Soars 5.09% Intraday on Strong Earnings, Procurement Wins and Dividend Announcement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | SHINEWAY PHARM Soars 5.09% Intraday on Strong Earnings, Procurement Wins and Dividend Announcement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-27 13:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SHINEWAY PHARM's stock price soared 5.09% during intraday trading on Friday, following the release of its annual financial results and other positive corporate announcements.</p><p>The company reported an annual profit increase of 13.1% to 950 million yuan for the fiscal year ended December 31, 2025, despite a decrease in overall revenue. Furthermore, the group successfully secured bids for eight key products in the National Chinese Patent Medicine Purchasing Alliance's centralized procurement program, covering major therapeutic areas. This success is expected to enhance future market demand and sales potential for its products.</p><p>Additionally, the company declared a first interim dividend of RMB 0.43 per share for the 2026 financial year, providing a return to shareholders. These combined positive developments likely contributed to increased investor confidence and the significant upward movement in the stock price.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02877","symbol_name":"神威药业","start_time":0,"source_url":"","article_id":"1110490559","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1110490559","pubTimestamp":1774588143,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"SHINEWAY PHARM's stock price soared 5.09% during intraday trading on Friday, following the release of its annual financial results and other positive corporate announcements.The company reported an...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02877":"神威药业"},"translate_title":"个股轨迹|神威药业盘中大涨5.09%盈利强劲、采购中标及派息公告","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02877":1},"content_text":"SHINEWAY PHARM's stock price soared 5.09% during intraday trading on Friday, following the release of its annual financial results and other positive corporate announcements.The company reported an annual profit increase of 13.1% to 950 million yuan for the fiscal year ended December 31, 2025, despite a decrease in overall revenue. Furthermore, the group successfully secured bids for eight key products in the National Chinese Patent Medicine Purchasing Alliance's centralized procurement program, covering major therapeutic areas. This success is expected to enhance future market demand and sales potential for its products.Additionally, the company declared a first interim dividend of RMB 0.43 per share for the 2026 financial year, providing a return to shareholders. These combined positive developments likely contributed to increased investor confidence and the significant upward movement in the stock price.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}